Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02892266 · ClinicalTrials.gov registry record
Post-Traumatic Stress Symptoms (PTSS) in Transplant Recipients
A clinical trial of Solid Organ Transplant Recipients and Parent(s)/Guardian of Referenced Transplant Recipients, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 124
- Enrollment target
- 13
- Study locations
NCT02892266: Completed study of Solid Organ Transplant Recipients and Parent(s)/Guardian of Referenced Transplant Recipients, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT02892266 is a study of Solid Organ Transplant Recipients and Parent(s)/Guardian of Referenced Transplant Recipients that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 124 participants. The trial reports 13 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02892266, a study of Solid Organ Transplant Recipients and Parent(s)/Guardian of Referenced Transplant Recipients, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 124 participants
- Enrollment target
- 13
- Study locations
Study Summary
This study is conducted to better understand Post-Traumatic Stress Symptoms (PTSS) in adolescent transplant recipients and their parent/guardian and to see if PTSS play a role in the way adolescent transplant recipients take their prescribed medicine. Target population: medically stable adolescent solid organ (e.g., heart, kidney, liver, lung, small bowel) transplant recipients and their parent(s)/guardian.
Primary Outcome
Defined by fluctuation in medication blood levels. Calculated as the standard deviation (variation) of a minimum of 3 outpatient tacrolimus trough levels, obtained for one year, consisting of 6 months prior to study enrollment plus 6 months post study enrollment.
Conditions Studied
Interventions
- OTHER Assessment of adherence, mental health, behavioral, quality of life and biological constructs
Study Locations (13)
California
- Ronald Reagan UCLA Medical Center: Pediatric Transplantation - Los Angeles
- Lucile Salter Packard Children's Hospital at Stanford: Pediatric Transplantation - Palo Alto
- UCSF Benioff Children's Hospital: Pediatric Transplantation - San Francisco
Ohio
- Cincinnati Children's Hospital Medical Center: Pediatric Transplantation - Cincinnati
- Nationwide Children's Hospital - Columbus
Texas
- University of Texas Southwestern/Children's Medical Center: Pediatric Transplantation - Dallas
- Texas Children's Hospital: Pediatric Transplantation - Houston
Florida
- University of Miami, Jackson Memorial Hospital: Pediatric Transplantation - Miami
Illinois
- Ann and Robert H. Lurie Children's Hospital of Chicago: Pediatric Transplantation - Chicago
Massachusetts
- Boston Children's Hospital: Pediatric Transplantation - Boston
Missouri
- St. Louis Children's Hospital: Pediatric Transplantation - St Louis
New York
- Columbia University Medical Center: Pediatric Transplantation - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-11-24 |
What the finished NCT02892266 record still lists
NCT02892266 is an observational study that tracks outcomes without assigning an intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Solid Organ Transplant Recipients appearing as the primary indexed condition, and to 1 intervention - of which Assessment of adherence, mental health, behavioral, quality of life and biological constructs is the first listed.
NCT02892266 lists 13 locations in 9 states (California, Ohio, Texas).
Frequently Asked Questions
What is clinical trial NCT02892266 about?
NCT02892266 is a clinical study titled "Post-Traumatic Stress Symptoms (PTSS) in Transplant Recipients". This study is conducted to better understand Post-Traumatic Stress Symptoms (PTSS) in adolescent transplant recipients and their parent/guardian and to see if PTSS play a role in the way adolescent transplant recipients take their prescribed medicine. Target population: medically stable adolescent ...
What is the current status of trial NCT02892266?
This trial is currently completed. The enrollment target is 124 participants. The study started on 2016-09. Estimated completion is 2018-11-24.
What conditions does trial NCT02892266 study?
This clinical trial studies the following conditions: Solid Organ Transplant Recipients, Parent(s)/Guardian of Referenced Transplant Recipients.
What interventions are being tested in trial NCT02892266?
The interventions under investigation include: Assessment of adherence, mental health, behavioral, quality of life and biological constructs (OTHER).
Who is sponsoring clinical trial NCT02892266?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02892266 being conducted?
This trial has 13 study locations across California, Florida, Illinois, Massachusetts, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523014 · 124 participants · Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- NCT02670707 · 124 participants · Phase 3
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- NCT02830724 · 124 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- NCT04748809 · 124 participants · NA
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia